The diagnosis of prostate cancer metastatic to bone currently is made
with plain x-rays, radio-nuclide bone scans, and acid and alkaline pho
sphatases. We used magnetic resonance imaging (MRI) in 18 patients wit
h known prostate cancer to resolve conflicting evidence of metastases
found on bone scans, plain films and serum enzyme determinations. Of 8
bone scans interpreted as positive MRI was read as negative for metas
tatic disease in 2. Of 5 negative bone scans 1 MRI study was interpret
ed as positive. All 5 equivocal bone scans demonstrated no osseous les
ions on MRI. In addition, in 6 patients with evidence of bone metastas
es the serial MRI scans following hormonal therapy demonstrated radiog
raphic and clinical improvement. We conclude that MRI is helpful in th
e diagnosis of metastatic prostate cancer when other radiographic exam
inations are enigmatic and that MRI can be used to determine the respo
nse to hormonal treatment.